SORASIO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 116
EU - Europa 44
AS - Asia 16
AF - Africa 1
SA - Sud America 1
Totale 178
Nazione #
US - Stati Uniti d'America 115
IT - Italia 25
IN - India 7
DE - Germania 6
FR - Francia 5
VN - Vietnam 4
CN - Cina 3
DK - Danimarca 3
GB - Regno Unito 3
BR - Brasile 1
CA - Canada 1
IL - Israele 1
MK - Macedonia 1
SE - Svezia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 178
Città #
Fairfield 21
Torino 16
Ashburn 14
Buffalo 10
Cambridge 9
Seattle 8
Houston 6
Duncan 5
Woodbridge 5
Dong Ket 4
Santa Cruz 4
New York 3
Ann Arbor 2
Chicago 2
Columbus 2
Lake Forest 2
Bangalore 1
Bedford 1
Beijing 1
Council Bluffs 1
Doruk 1
Faenza 1
Freiburg 1
Giarre 1
Great Dunmow 1
Hangzhou 1
Jersey City 1
Leawood 1
Los Angeles 1
Muizenberg 1
New Delhi 1
Ottawa 1
Paris 1
Phoenix 1
Prilep 1
San Francisco 1
San Jose 1
Stockholm 1
Turin 1
University Park 1
Wilmington 1
Wuhan 1
Totale 139
Nome #
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma, file e27ce42c-91d4-2581-e053-d805fe0acbaa 137
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma, file e27ce42c-9e99-2581-e053-d805fe0acbaa 24
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases, file e27ce434-b4cb-2581-e053-d805fe0acbaa 24
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi, file e27ce432-9266-2581-e053-d805fe0acbaa 1
Totale 186
Categoria #
all - tutte 329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 7 6
2019/202042 3 5 2 8 2 3 6 2 5 1 3 2
2020/202131 3 2 2 2 4 5 1 3 1 2 1 5
2021/202231 3 1 4 0 2 0 0 0 3 5 8 5
2022/202330 1 3 9 6 3 3 1 2 0 1 1 0
2023/20244 0 0 0 1 0 0 1 1 0 0 1 0
Totale 186